ghk-cu promotes wound healing Food-Derived Tripeptide–Copper Self-Healing Hydrogel for Infected GHK-Cu Peptide: Benefits for Tissue

Section 140, lot 23416

In the phase III ORATORIO trial, 732 patients with primary progressive multiple sclerosis were randomly assigned in a 2:1 ratio to receive ocrelizumab 600 mg or placebo every 24 weeks for at least 120 weeks until the primary endpoint was met: 544 completed the double-blind period, of which 527 entered the open-label extension (75)

Dihexa characterization paper

Safety First: What to Watch for on GHK-Cu dosage protocol

The answer shapes which peptide or combination makes clinical sense

Senolytics, drugs that eliminate senescent cells, show great potential in oncology, offering the possibility of selectively targeting cancer cells that enter a state of senescence without affecting healthy cells